Lumida
/GH
⌘K
Guardant Health Inc

Guardant Health Inc

GH
$157.38USD-1.04%-1.65 today

MARKET CAP

21.1B

P/E (TTM)

FWD P/E

DAY RANGE

$156 – $161

52W RANGE

$53
$177

AI Summary

Stalk
StalkMedium

GH is in a robust Stage 2 advance with a parabolic acceleration above rising EMAs, anchoring bullish medium- and long-term biases. However, extreme overbought conditions and an exhaustion candle near the peak suggest near-term timing is unfavorable. Execution should be deferred until a pullback into the rising EMA 9/21 support zone or prior consolidation range confirms renewed buying interest.

  • Q2 2026 revenue reached $335M, up 44% YoY driven by Guardant360 and Shield tests.
  • Oncology test volumes climbed 63% YoY to ~104K tests, reflecting strong market adoption.
  • Patent infringement verdict carries $245.2M damages, straining cash flows and management focus.
Full analysis →

Buying

11

institutions

Selling

10

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

SELL7.62 M1.14 B+-3.93 M+7.2%0.02%
MM

Millennium Management LLC

Q2 2026

BUY1.69 M252.82 M+668.56 K+169.2%0.09%
CA

Citadel Advisors LLC

Q2 2026

BUY1.62 M243.40 M+684.09 K+180.8%0.03%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY965.11 K144.80 M+214.27 K+108.8%0.16%
CC

Cadian Capital Management, LP

Q2 2026

SELL757.39 K113.63 M+-22.25 K+57.8%8.60%
JC

Jpmorgan Chase & Co

Q2 2026

BUY549.09 K85.33 M+244.77 K+225.3%0.00%
FC

Farallon Capital Management, L.l.c.

Q2 2026

BUYNEW322.20 K48.34 M+322.20 K+0.0%0.22%
CP

California Public Employees Retirement System

Q2 2026

BUY228.88 K34.34 M+13.42 K+72.5%0.02%
CC

Casdin Capital, LLC

Q2 2026

SELL185.00 K27.76 M+-130.00 K-4.6%1.39%
JH

Janus Henderson Group Plc

Q1 2026

BUY280.69 K25.92 M+163.19 K+116.0%0.01%
BA

Balyasny Asset Management L.P.

Q2 2026

BUYNEW124.37 K18.66 M+124.37 K+0.0%0.02%
AC

Aqr Capital Management LLC

Q2 2026

SELL121.67 K18.25 M+-9.63 K+50.5%0.01%
PA

Perceptive Advisors LLC

Q2 2026

SELL41.33 K6.20 M+-558.67 K-88.8%0.09%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW19.68 K2.95 M+19.68 K+0.0%0.02%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY18.44 K2.77 M+5.38 K+129.3%0.00%
MG

Man Group Plc

Q2 2026

BUY17.95 K2.69 M+8.27 K+201.1%0.00%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

SELL17.94 K2.69 M+-737.77 K-96.1%0.00%
FC

Farallon Capital Management LLC

Q1 2026

SELL8.00 K738.96 K+-101.00 K-93.4%0.00%
BA

Bridgewater Associates, LP

Q2 2026

SELL4.24 K636.73 K+-9.11 K-48.4%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-337.60 K-100.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL0.000.00+-10.00 K-100.0%0.00%